| Filed On | Filing |
|---|---|
| 29 Apr 2025 |
Form 4/A: Strahlman Ellen R, Director
Received 3,000 shares as a grant or award |
| 29 Apr 2025 |
Form 4/A: Palanki Ram, Director
Received 3,000 shares as a grant or award |
| 29 Apr 2025 |
Form 4/A: Mather Charles E Iv, Director
Received 8,000 shares as a grant or award |
| 29 Apr 2025 |
Form 4/A: Jacobson Rachel, Director
Received 3,000 shares as a grant or award |
| 29 Apr 2025 |
Form 4/A: Ianchulev Tsontcho, Director
Received 5,000 shares as a grant or award |
| 29 Apr 2025 |
Form 4/A: Geltzeiler Michael S, Director
Received 5,000 shares as a grant or award |
| 16 May 2023 |
Form 4/A: Mather Charles E Iv, Director
Bought 4,000 shares ($13.6K) |
| 29 Jun 2022 |
Form 4/A: Benjamin Stephen Keith, Director
Granted 4,745 Stock Option (right to buy) |
| 29 Jun 2022 |
Form 4/A: Jacobson Rachel, Director
Granted 4,745 Stock Option (right to buy) |
| 21 Jul 2021 |
Form 4/A: Clasby Jennifer G, VP, Regulatory and Clinical
Received 24,510 shares by exercise or conversion ($47.8K) · Gave up 13,675 shares to cover exercise price or tax ($74.1K) |
Loading...